Good morning :)
Place Order
Add to Watchlist

Krebs Biochemicals and Industries Ltd

KREBSBIO Share Price

82.710.00% (+0.00)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹178 cr, stock is ranked 2,567

Stock is 4.73x as volatile as Nifty

KREBSBIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

With a market cap of ₹178 cr, stock is ranked 2,567

Stock is 4.73x as volatile as Nifty

KREBSBIO Performance & Key Metrics

KREBSBIO Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-6.6216.54
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.596.400.79%

KREBSBIO Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

KREBSBIO Company Profile

Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.

KREBSBIO Similar Stocks (Peers)

Compare with peers Compare with peers 

KREBSBIO Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.50
36.50
1Y Return
4.00%
4.00%
Buy Reco %
87.10
87.10
PE Ratio
22.64
22.64
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
PE Ratio
59.13
59.13
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
PE Ratio
18.58
18.58
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
PE Ratio
52.73
52.73
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
Compare with Peers

KREBSBIO Forecast

KREBSBIO Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

KREBSBIO

KREBSBIO

Income

Balance Sheet

Cash Flow

KREBSBIO Income Statement

KREBSBIO Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 5.44%, vs industry avg of 10.1%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.01%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue3.6534.1348.2033.7854.3260.8652.7550.8744.0244.02
Raw Materialssubtract1.3417.1220.9919.1825.6246.1819.815.5258.3458.35
Power & Fuel Costsubtract0.708.6211.7010.2815.9122.2314.8022.01
Employee Costsubtract5.6311.4914.4114.5615.3014.9615.5416.17
Selling & Administrative Expensessubtract2.523.433.834.013.396.114.574.50
Operating & Other expensessubtract1.781.986.593.9411.054.2213.2010.95
Depreciation/Amortizationsubtract4.234.154.404.685.126.306.566.776.696.69
Interest & Other Itemssubtract3.495.176.296.006.285.392.974.695.915.91
Taxes & Other Itemssubtract0.000.000.000.000.000.000.000.000.020.02
EPS-11.56-12.53-12.97-16.67-15.07-21.63-11.46-9.16-12.49-12.50
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

KREBSBIO Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

KREBSBIO Stock Peers

KREBSBIO Past Performance & Peer Comparison

KREBSBIO Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Krebs Biochemicals and Industries Ltd-6.6216.54
Sun Pharmaceutical Industries Ltd36.505.500.96%
Cipla Ltd22.643.821.08%
Torrent Pharmaceuticals Ltd59.1314.890.18%

KREBSBIO Stock Price Comparison

Compare KREBSBIO with any stock or ETF
Compare KREBSBIO with any stock or ETF
KREBSBIO
Loading...

KREBSBIO Holdings

KREBSBIO Shareholdings

KREBSBIO Promoter Holdings Trend

KREBSBIO Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

KREBSBIO Institutional Holdings Trend

KREBSBIO Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

KREBSBIO Shareholding Pattern

KREBSBIO Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding72.74%0.00%0.00%0.50%26.76%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

KREBSBIO Shareholding History

KREBSBIO Shareholding History

Dec '23MarJunSepDec '24Mar0.50%0.50%0.50%0.50%0.50%0.50%

KREBSBIO Insider Trades & Bulk Stock Deals

KREBSBIO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing KREBSBIO stock

smallcases containing KREBSBIO stock

Looks like this stock is not in any smallcase yet.

KREBSBIO Events

KREBSBIO Events

KREBSBIO Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

KREBSBIO has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

KREBSBIO Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

KREBSBIO has not given any dividends in last 5 years

KREBSBIO Dividends

KREBSBIO Dividends

Hmm, looks like data is unavailable here. Please come back after some time

KREBSBIO Stock News & Opinions

KREBSBIO Stock News & Opinions

Earnings
Krebs Biochemicals & Industries reports standalone net loss of Rs 8.27 crore in the March 2025 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 8.27 crore in the quarter ended March 2025 as against net loss of Rs 5.85 crore during the previous quarter ended March 2024. Sales declined 49.04% to Rs 6.10 crore in the quarter ended March 2025 as against Rs 11.97 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 26.94 crore in the year ended March 2025 as against net loss of Rs 19.73 crore during the previous year ended March 2024. Sales declined 14.10% to Rs 43.31 crore in the year ended March 2025 as against Rs 50.42 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales6.1011.97 -49 43.3150.42 -14 OPM %-88.69-26.07 --34.70-17.29 - PBDT-6.68-4.18 -60 -20.23-12.96 -56 PBT-8.25-5.85 -41 -26.92-19.73 -36 NP-8.27-5.85 -41 -26.94-19.73 -37 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Krebs Biochemicals & Industries to hold board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Krebs Biochemicals & Industries reports standalone net loss of Rs 7.74 crore in the December 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 7.74 crore in the quarter ended December 2024 as against net loss of Rs 4.98 crore during the previous quarter ended December 2023. Sales declined 11.63% to Rs 11.47 crore in the quarter ended December 2024 as against Rs 12.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales11.4712.98 -12 OPM %-41.06-16.10 - PBDT-6.02-3.25 -85 PBT-7.74-4.98 -55 NP-7.74-4.98 -55 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Krebs Biochemicals & Industries to convene board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Spotlight
Krebs Biochemicals & Industries Ltd leads losers in 'B' group

Uflex Ltd, Raghav Productivity Enhancers Ltd, Ruby Mills Ltd and Shree Rama Multi-Tech Ltd are among the other losers in the BSE's 'B' group today, 28 November 2024.Krebs Biochemicals & Industries Ltd tumbled 10.00% to Rs 112.86 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 15166 shares were traded on the counter so far as against the average daily volumes of 15331 shares in the past one month.Uflex Ltd crashed 6.75% to Rs 540.05. The stock was the second biggest loser in 'B' group.On the BSE, 15520 shares were traded on the counter so far as against the average daily volumes of 5142 shares in the past one month.Raghav Productivity Enhancers Ltd lost 6.20% to Rs 1559.5. The stock was the third biggest loser in 'B' group.On the BSE, 9936 shares were traded on the counter so far as against the average daily volumes of 7019 shares in the past one month.Ruby Mills Ltd shed 5.32% to Rs 271.4. The stock was the fourth biggest loser in 'B' group.On the BSE, 4250 shares were traded on the counter so far as against the average daily volumes of 5650 shares in the past one month.Shree Rama Multi-Tech Ltd fell 5.00% to Rs 47.32. The stock was the fifth biggest loser in 'B' group.On the BSE, 2.49 lakh shares were traded on the counter so far as against the average daily volumes of 1.68 lakh shares in the past one month.Powered by Capital Market - Live

7 months agoCapital Market - Live
Spotlight
Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Ruby Mills Ltd, 3P Land Holdings Ltd, Godavari Biorefineries Ltd and RPP Infra Projects Ltd are among the other gainers in the BSE's 'B' group today, 26 November 2024.Krebs Biochemicals & Industries Ltd spiked 19.99% to Rs 118.23 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 74997 shares were traded on the counter so far as against the average daily volumes of 7351 shares in the past one month. Ruby Mills Ltd surged 19.99% to Rs 249.1. The stock was the second biggest gainer in 'B' group. On the BSE, 15233 shares were traded on the counter so far as against the average daily volumes of 1676 shares in the past one month. 3P Land Holdings Ltd soared 19.99% to Rs 65.73. The stock was the third biggest gainer in 'B' group. On the BSE, 24431 shares were traded on the counter so far as against the average daily volumes of 7340 shares in the past one month. Godavari Biorefineries Ltd advanced 17.00% to Rs 328.9. The stock was the fourth biggest gainer in 'B' group. On the BSE, 92054 shares were traded on the counter so far as against the average daily volumes of 1.03 lakh shares in the past one month. RPP Infra Projects Ltd spurt 16.53% to Rs 194.25. The stock was the fifth biggest gainer in 'B' group. On the BSE, 93348 shares were traded on the counter so far as against the average daily volumes of 13019 shares in the past one month. Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September 2024 as against net loss of Rs 3.57 crore during the previous quarter ended September 2023. Sales declined 13.63% to Rs 12.86 crore in the quarter ended September 2024 as against Rs 14.89 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.8614.89 -14 OPM %-21.15-6.04 - PBDT-4.05-1.86 -118 PBT-5.76-3.57 -61 NP-5.76-3.57 -61 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter

Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024 as against net loss of Rs 5.33 crore during the previous quarter ended June 2023. Sales rose 21.83% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 10.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8910.58 22 OPM %-16.99-24.76 - PBDT-3.48-3.68 5 PBT-5.17-5.33 3 NP-5.17-5.33 3 Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Krebs Biochemicals and Industries Ltd (KREBSBIO) today?

    The share price of KREBSBIO as on 10th July 2025 is ₹82.71. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Krebs Biochemicals and Industries Ltd (KREBSBIO) share?

    The past returns of Krebs Biochemicals and Industries Ltd (KREBSBIO) share are
    • Past 1 week: -4.49%
    • Past 1 month: -18.40%
    • Past 3 months: 14.22%
    • Past 6 months: -9.17%
    • Past 1 year: 4.45%
    • Past 3 years: -19.03%
    • Past 5 years: 11.24%

  3. What are the peers or stocks similar to Krebs Biochemicals and Industries Ltd (KREBSBIO)?
  4. What is the market cap of Krebs Biochemicals and Industries Ltd (KREBSBIO) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krebs Biochemicals and Industries Ltd (KREBSBIO) is ₹178.33 Cr as of 10th July 2025.

  5. What is the 52 week high and low of Krebs Biochemicals and Industries Ltd (KREBSBIO) share?

    The 52-week high of Krebs Biochemicals and Industries Ltd (KREBSBIO) is ₹129.07 and the 52-week low is ₹66.12.

  6. What is the PE and PB ratio of Krebs Biochemicals and Industries Ltd (KREBSBIO) stock?

    The P/E (price-to-earnings) ratio of Krebs Biochemicals and Industries Ltd (KREBSBIO) is -6.62. The P/B (price-to-book) ratio is 16.54.

  7. Which sector does Krebs Biochemicals and Industries Ltd (KREBSBIO) belong to?

    Krebs Biochemicals and Industries Ltd (KREBSBIO) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Krebs Biochemicals and Industries Ltd (KREBSBIO) shares?

    You can directly buy Krebs Biochemicals and Industries Ltd (KREBSBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.